This document covers Antidepressants, Cardiovascular Safety of NSAIDs and Smoking Cessation advice for Pharmacists.
The coverage of antidepressants is a thorough examination of the trial of Escitalopram (Cipralex) versus Citalopram (Cipramil) that has already been covered here with the same key message delivered but in greater detail.
The coverage of the Cardiovascular Safety of NSAIDs has also been covered on this site but again the MeReC covers the topic in greater detail and again the take home message is the same.
Action: The MeRec Extra is a valuable source of information for Primary Care Prescribers. If your practice involves prescribing of NSAIDs or Antidepressants this publication will be of interest.
|« Flomax replaced by Flomaxtra||Suicide Warning on Atomoxetine »|